NCT05800938View on ClinicalTrials.gov

The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

December 6, 2022

Study Completion Date

December 6, 2022

Conditions
Intrauterine Growth Restriction
Interventions
DRUG

Isosorbid mononitrate

Imdur tablets were given twice daily for 4 weeks

DRUG

Placebo

Placebo tablets were given twice daily for 4 weeks

Trial Locations (1)

11591

Faculty of Medicine, Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER